We hypothesized (a) that HER2-positive tumor cells have no preferential spatial distribution within a given GC and (b) that a high concordance of the HER2 status between biopsy specimens and the resection specimen can be achieved with six tumor-containing biopsy specimens. The gene discussed is ERBB2; the disease is neoplasm.